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Abstract
The neural crest is a highly migratory cell population, unique to vertebrates, that forms much of
the craniofacial skeleton and peripheral nervous system. In exploring the cell biological basis
underlying this behavior, we have identified an unconventional myosin, myosin-X (Myo10) that is
required for neural crest migration. Myo10 is highly expressed in both premigratory and migrating
cranial neural crest (CNC) cells in Xenopus embryos. Disrupting Myo10 expression using
antisense morpholino oligonucleotides leads to impaired neural crest migration, but only a slight
delay in induction. In vivo grafting experiments reveal that Myo10-depleted CNC cells migrate a
shorter distance and fail to segregate into distinct migratory streams. Finally, in vitro cultures and
cell dissociation-reaggregation assays suggest that Myo10 may be critical for production of cell
protrusions and cell-cell adhesion. These results demonstrate an essential role for Myo10 in
normal cranial neural crest migration and suggest a link to cell-cell interactions and formation of
processes.
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Introduction
The neural crest is a transient population of migratory cells present in all vertebrate
embryos. Originating at the border of neural plate and non-neural ectoderm, this population
becomes specified during gastrulation and neurulation via a complex cascade of signaling
pathways and transcription factors (Mayor and Aybar, 2001; Sauka-Spengler and Bronner-
Fraser, 2006, 2008). Immediately following neurulation, presumptive neural crest cells are
initially contained within the central nervous system. They first become morphologically
identifiable when they delaminate from the dorsal neural tube and begin migrating along
defined pathways throughout the periphery. Upon reaching their destinations, they
differentiate into a wide variety of cell types, including neurons and glia of the peripheral
nervous system, pigment cells, and much of the craniofacial bone and cartilage. The
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molecular and cell biological factors underlying neural crest migration and differentiation
are subjects of much interest.
In screening for novel players involved in neural crest induction and migration, we have
identified an unconventional myosin, Myosin-X (Myo10), in premigratory and migrating
cranial neural crest (CNC) cells. Like all myosins, Myo10 contains a motor domain that
interacts with actin and hydrolyzes ATP. In addition, it possesses three IQ motifs that can
bind to calmodulin or calmodulin-like light chain, and a coiled-coil domain for dimerization.
The tail of Myo10 has a PEST region for proteolytic cleavage, three pleckstrin homology
(PH) domains implicated in signaling through phosphatidylinositol phospholipids, and at the
C-terminus, a myosin tail homology 4 (MyTH4) domain and a FERM domain important for
binding microtubules and β-integrin (Sellers, 2000; Sousa and Cheney, 2005). This structure
suggests that Myo10 may mediate membrane-cytoskeleton interactions. Studies in cultured
mammalian cells show that Myo10 is expressed at the edges of lamellipodia, membrane
ruffles, and the tips of filopodia. Consistent with its location, Myo10 is required for the
formation and extension of filopodia. It not only induces the formation of filopodia by
convergence of actin bundles through dimerization, but also promotes filopodial extension
and stabilization by transporting integrin and actin binding proteins Mena/VASP to their tips
(Berg et al., 2000; Berg and Cheney, 2002; Tokuo and Ikebe, 2004; Zhang et al., 2004;
Bohil et al., 2006; Tokuo et al., 2007). In addition, Myo10 has been implicated in other
processes such as neurite outgrowth (Zhu et al., 2007), endothelial cell migration (Pi et al.,
2007), and the assembly of meiotic and mitotic spindles (Weber et al., 2004; Woolner et al.,
2008).
Here, we explore the role Myo10 in embryonic development and find that it is highly
expressed in premigratory and migrating CNC cells in Xenopus. Furthermore, loss-of-
function experiments establish a critical role for Myo10 in the migration of CNC cells in
vivo and in vitro, likely due to alterations in cell adhesive properties.
Materials and Methods
Embryo manipulations, morpholino oligonucleotides and RNA preparation—
Xenopus embryos, both pigmented and albino, were microinjected with capped RNAs or
MOs as described (Chang et al., 1997), using a standard control MO (Gene Tools Inc.) and
two Myo10 MOs (Myo10-MO1: 5'-CCCCTCTGTGAAATATTCCTCCATG-3' and Myo10-
MO2: 5'-TCTCCCTCTGCTCAGCCAGTATATA-3') that hybridize to −1 to 24 position
and −26 to −2 position relative to the translational start site of XMyo10 (Genbank accession
no. AY616034). RNAs of nuclear beta-galactosidase (nβGal), nuclear EGFP, and Myo10
open reading frame (kindly provided by Dr. William M. Bement), Wnt3a, noggin,
membrane-tethered EGFP (kindly provided by Dr. Chenbei Chang) were synthesized with
Ambion mMessage mMachine kit. To selectively target the neural crest, MOs and mRNAs
were injected into dorsal animal region of 4–8 cell stage embryos. MOs were injected at 10
ng per embryo and 50–100 pg of Myo10 RNA was coinjected in rescue experiment. For
tracing purpose, nβGal or EGFP was injected at 0.2 ng per embryo.
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Animal Cap Assay—In screening for genes involved in neural crest development, Wnt3a
conditioned media was obtained as previously described (Shibamoto et al., 1998) and a
stock was prepared in DMEM containing 0.5% BSA. Recombinant mouse noggin (R&D
Systems) was used at a concentration of 0.5 μg/ml. Animal caps were collected at late stage
9 and cultured in Wnt3a-conditioned media and noggin protein or in control media with
noggin alone. To test myo10's requirement for neural crest induction, mRNAs encoding
Wnt3a and noggin, with or without myo10-MO were injected into animal region of two-cell
stage embryos. Animal caps were dissected at late blastula stages and cultured in 0.5xMMR
till collected at late gastrula to early neurula stages for in situ hybridization.
Red-Gal staining, in situ hybridization, immunohistochemistry, TUNEL assay,
and cartilage staining—For lineage tracing, embryos coinjected with nβGal were fixed
for half an hour in MEMFA, rinsed twice with PBS and stained with the Red Gal substrate
(Research Organics) until they turned visibly red in color. The embryos were re-fixed for 2
hours in MEMFA and in situ hybridization or whole mount immunohistochemistry was
performed as previously described (Chang et al., 1997). Anti-phosphorylated histone H3
antibody was used at 5 μg/ml. The secondary antibodies were used at 1:1000 to 1:2000
dilutions. TUNEL assay was performed as described by Hensey and Gautier (1998).
Phosphohistone and TUNEL stained embryos were either cleared in benzyl benzoate/benzyl
alcohol solution and imaged directly, or embedded in paraffin and sectioned via microtome
before imaging. Cartilage staining was performed according to Dr. Richard Harland's lab
protocol (http://tropicalis.berkeley.edu/home/gene_expression/cartilage-stain/alcian.html).
Reverse transcription and polymerize chain reaction (RT-PCR)—Total RNA was
extracted from cranial neural crest explants with RNAqueous-Micro kit (Ambion), reverse
transcribed and PCR for myo10 expression. The following primer pairs were used: Myo10-
U: 5'-TGGGAACTTTGGATGTGGGTCTCA-3'; Myo10-D: 5'-
TGAGCAGTTTGGTGTAGAGCCTGT-3'; EF1α-U: 5'-
CAGATTGGTGCTGGATATGC-3'; EF1α-D: 5'-ACTGCCTTGATGACTCCAAG-3'.
Cranial neural crest explant cultures and grafting experiment—Cranial neural
crest (CNC) explants were dissected from stage 13–16 embryos as previously described
(Borchers et al., 2000; Alfandari et al., 2003; DeSimone et al., 2005). Explants were plated
onto fibronectin (FN, 20μ/ml in PBS)-coated dishes in MBSH (High Salt Modified Barth's
Saline) media and their behavior was photographically documented every 2–3 hours for up
to 8 hours. Spreading and segregation of the explants were compared by measuring the
relative surface area and counting the number of segments. For observation of cell migration
and membrane protrusions, CNC explants labeled with membrane-EGFP were plated on
FN-coated coverslips and cell behaviors were recorded by time-lapse movies (3 hours with 3
minute frame intervals) using a Zeiss LSM5 PASCAL confocal microscope. For grafting
experiment, cranial neural crest explants were dissected similarly from EGFP-labeled donor
embryos and inserted isotopically and isochronically into unlabelled host embryos from
which cranial neural crest tissue was removed. The grafted embryos were allowed to heal in
MBSH media for 3 hours and then transferred to 0.1xMMR before imaged at late tailbud
stages.
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Cell adhesion assays—To analyze cell-cell adhesion, CNC explants were dissected
from stage 14–16 embryos and dissociated for one hour in calcium- and magnesium-free
buffer (CMFB). Loose cells were transferred to 0.5xMMR in agarose-coated dishes and
allowed to aggregate by orbital horizontal shaking overnight. The number of large cell
clusters that indicate cell reaggregation was counted and compared. To observe cell behavior
on fibronectin substrates, CNC explants were dissected and dissociated as described above.
Loose cells were then plated onto FN-coated dish in high salt buffer MBSH. Cells were
given one hour to settle on FN before been imaged with Zeiss Axiovert35. Cells that became
polarized on FN were counted and compared.
Results
Isolation of Xenopus Myo10 as a gene up-regulated during neural crest induction
To identify novel genes essential for neural crest induction and/or early migration, we took
advantage of animal cap assays, in which neural crest genes are robustly expressed in naive
ectodermal tissue treated with a combination of Wnt signals and BMP inhibitors. Treating
animal caps with BMP antagonists, chordin or noggin, induces neural genes such as NCAM
whereas treating animal caps with both BMP antagonist and Wnt induces neural crest genes
such as Snail2 (Slug) (LaBonne and Bronner-Fraser, 1998). Animal caps were dissected at
late stage 9 and cultured in standard media containing noggin protein alone or both noggin
and Wnt3a proteins until control embryos reached stage 18. Total RNA and cDNA were
prepared from animal caps receiving each treatment and subjected to cDNA microarray
analysis as previously described (Baldessari et al., 2005; Peiffer et al., 2005). In this manner,
we identified genes up-regulated under conditions of neural crest induction compared with
neural induction. One of these, Myo10 was up-regulated 2.3 fold. This set the stage for
examining the molecular mechanisms of Myo10 function during neural crest development.
Myo10 is expressed in neural crest cells during early Xenopus development
Since Myo10 expression was enhanced as a consequence of in vitro neural crest induction,
we next examined its temporal and spatial expression pattern to better understand the time
during which it may be functionally important. To this end, we performed in situ
hybridization in embryos ranging from gastrula to tailbud stages (Figure1). The onset of
Myo10 expression occurred at late gastrula stages (st.12.5–13), where transcripts were
expressed at the border of the forming neural plate, the site of initial neural crest induction.
During neurula stages (st.14–st.18), as the neural folds fuse to form the neural tube, the
intensity of Myo10 increased in the cranial neural crest (CNC) region. Myo10 demarcated
both premigratory neural crest cells within the dorsal neural tube as well as streams of
migrating neural crest cells. By late neurula stages, Myo10 expressing neural crest cells
were migrating towards the forming branchial arches. During tailbud stages, its expression
decreased in the cranial neural tube but remained notable in cranial ganglia. In addition to
the neural crest, Myo10 was also detected in the developing somites and in portions of the
brain.
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Myo10 MO disrupts the expression of neural crest genes
The expression pattern of Myo10 in both premigratory and migratory CNC cells is
consistent with a possible role in their formation and/or migration. To test its functional
importance, we performed loss-of-function experiments using anti-sense morpholino
oligonucleotides (MOs) against Myo10. Myo10-MOs, together with nuclear beta-
galactosidase (nβGal) RNA as a lineage tracer, were injected into one side of the embryo
during early cleavage stages (2–8 cell stages), such that the contralateral uninjected side
served as an internal control. Sister embryos were injected with control-MO in an analogous
manner. In control embryos at neurula and tailbud stages, in situ hybridization with probes
against neural crest markers Snail2, Sox10 and Twist revealed symmetric patterns on both
injected and uninjected sides. In contrast, neural crest marker genes appeared to be down-
regulated in Myo10-MO injected embryos (Figure 2A). At neurula stages, Snail2, Sox10,
and Twist expression levels were markedly reduced on the Myo10-MO injected side in ~3/4
of injected embryos (68%, 76%, and 76% of embryos for Snail2, Sox10 and Twist,
respectively; quantified in Figure 2B).
The reduction in transcript levels could reflect either a decrease in cell number due to
alterations in cell proliferation/death or diminution of transcript levels. To discriminate
between these possibilities, we sectioned embryos to count the number of cells on control
versus experimental sides (Figure 3). We noted that the cell number was not significantly
altered but the levels of transcript appeared diminished. In addition, cell proliferation was
assayed with phosphohistone H3 and cell death with TUNEL staining. Neither was
significantly affected (Figure 4). This diminution in transcript levels likely reflects a
developmental delay, since neural crest markers were expressed at normal levels by tailbud
stages.
To directly test the possible effects of Myo10-MO on neural crest induction, we turned to an
animal cap assay. Animal caps were dissected at late stage 9 from embryos injected with
Wnt3a and Noggin mRNA, with or without Myo10-MO. In situ hybridization analysis
reveals that Snail2 and Twist are expressed in a slightly delayed fashion in the presence of
Myo10-MO, but identical to positive controls by stage 14 (equivalent stage of sibling
embryos; Figure 5). These results suggest that Myo10 knock-down does not significantly
affect induction of neural crest markers.
In contrast, severe migration defects were noted. As CNC cells migrated laterally to
populate the branchial arches on the control side, Sox10- and Twist-positive neural crest
cells on the Myo10-MO treated side appeared highly disorganized (>70% of embryos
exhibited defective neural crest migration; 71% and 73% for Sox10 and Twist, respectively;
Figure 2A&C). Moreover, the distance traversed by CNC cell migration was reduced and
their paths of migration often appeared irregular. At both early and late stages, pan-neural
markers Sox3 and NCAM were expressed normally (Figure 2A and data not shown),
suggesting that the effect is specific to neural crest tissue. A second Myo10-MO yielded
similar results, with reduced expression of neural crest genes in 71% of neurula stage
embryos and disrupted CNC migratory patterns in 67% of tailbud stage embryos. This
defect was partially rescued by simultaneous injection of Myo10-MO2 with low levels of
Myo10 mRNA (only 32% and 18% of embryos with abnormal neural crest marker
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expression or migratory patterns at neurula and tailbud stages, respectively), confirming that
the MO effect is specific to the down-regulation of Myo10. In contrast to loss-of-function,
over-expression of Myo10 had only minor effects on levels of Snail2 expression (data not
shown).
Cranial neural crest cells migration and stream formation are abnormal after Myo10
knockdown
To examine the effects of Myo10 knock-down on neural crest cells in the absence of
surrounding tissue, CNC explants were dissected from early neurula stage embryos (st. 13–
14) and plated on fibronectin (FN) -coated dishes. After 6–8 hours, CNC cells of control-
MO injected explants spread extensively on the substrate and segregated into several
apparent lobes, reflecting the separate streams that, in vivo, migrate toward the branchial
arches. In contrast, the majority of Myo10-MO injected CNC explants failed to spread well.
Instead, the cells tended to dissociate from each other and remained round (Figure 6A). To
quantify this effect, the area of coherent cell spreading was measured for each explant at the
start and end point of the experiment and relative changes in area were calculated as a
measure of the degree of spreading. In addition, the number of distinct cell segments was
counted for each explant. The results, summarized in Figure 6B&C, reveal marked
differences between control-MO injected explants, which spread 2.85X and formed ~2.6
streams, versus Myo10-MO injected explants, which only spread 1.36X and formed ~1.3
streams. When 50–100pg of Myo10 RNA was co-injected with its MO, both cell spreading
and segregation were partially rescued (2.77X; 2.2 segments, respectively). Student t-test
confirmed that Myo10-MOs significantly affected both the degree of explant spreading and
the segregation into streams. This effect was abrogated by co-injection of a rescue mRNA
(p-values below 10−7 when comparing Myo10-MO with control or rescue, above 0.05 when
comparing control with rescue). This suggests that Myo10 is required for proper
organization of neural crest migratory streams and that its knockdown alters the adhesion of
CNC cells.
We next examined whether these defects were autonomous to the neural crest by grafting
MO-treated CNC back into a normal environment. To this end, a piece of CNC was
dissected from EGFP-labeled embryos at stages 14–16 and transplanted isotopically and
homotopically into an unlabeled host embryo. At tailbud stages, grafted control-MO injected
CNC cells migrated into the branchial arches in an organized manner (Figure 7A). In
contrast, the migration of Myo10-MO injected cells was grossly abnormal. They not only
failed to reach the ventral edge of the branchial arches, but also often migrated irregularly
such that the streams of migrating cells were indistinct and appeared fused. Confocal images
of the grafted cells suggest that there is a decrease in cell-cell adhesion between migrating
cranial neural crest cells after loss-of-function of Myo10 (Figure 7B). This defect was
rescued by co-injection of a low dose of Myo10 RNA, resulting in better separation of
streams that extended further ventrally. The dorsolateral distance migrated by the grafted
cells was measured in each embryo. While control-MO injected grafts migrated across over
75% of the dorsoventral body axis, Myo10-MO injected grafts only migrated 56% of the
distance. With the addition of 50–100pg Myo10 RNA, the migration of the grafted cells
recovered, such that they extended 78% of the lateral dimension. The grafts were also
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summarized into four categories according to their migration patterns (Figure 7C), revealing
that not only the distance of migration was reduced, the segregation between cell streams
was also disrupted. These results demonstrate that Myo10 is required in CNC cells
themselves for proper migration to the branchial arches. Furthermore, in embryos allowed to
develop to tadpole stages by which time craniofacial skeletal structures had formed, we
found that neural crest derived Meckel's cartilage (from the mandibular stream), ceratohyal
cartilage (from the hyoid stream), and ceratobranchial cartilage (from the branchial arches)
were either malformed or missing (Figure 8). Thus, the early migration defects have long-
term developmental consequences.
Myo10 is required for cell adhesion and formation of protrusions between cranial neural
crest cells in vitro
Cells actively modulate their adhesive properties in order to migrate properly. To directly
test if Myo10 is required for CNC cell migration, we examined the behavior of individual
neural crest cells plated onto fibronectin substrates in the presence and absence of Myo10-
MO. Control morpholino-treated neural crest cells adhered to the substrate, spread, actively
elicited processes, and were highly motile (Figure 9 and supplementary movie 1). In
contrast, Myo10-MO-treated cells adhered but generally failed to spread. They remained
rounded and underwent random small movements without directionality or polarization
(Figure 9 and supplementary movie 2). In contrast, addition of Myo10-MO plus Myo10
mRNA rescued the cell spreading, process formation, and motility (Figure 9 and
supplementary movie 3). These results suggest that Myo10 is important for eliciting cell
processes that lead to cell polarization and directional movement.
Finally, we performed a cell dissociation-reaggregation assay to examine effects on cell-cell
adhesion. CNC explants were dissected from early neurula embryos and dissociated in
calcium- and magnesium-free buffer. Loose cells then were transferred into 0.5xMMR and
gently agitated to allow cell contact. The degree of cell reaggregation between experimental
and control cultures was compared by counting the numbers of cell clusters with diameters
over 100 μm, using 50 control or 50 experimental explants per experiment (3 repeats). On
average, control-MO treated cells formed 72 large cell clusters while Myo10-MO treated
cells formed only 19–20 cell clusters of similar size under identical conditions. Co-injection
of MO with Myo10 mRNA gave partial rescue (average of 48 cell aggregates formed;
Figure 9C). Student t-test showed that the Myo10-MOs caused a significant reduction in the
ability of cell aggregation compared to controls and rescued conditions. These data suggest
an important role for Myo10 in cell-cell adhesion between CNC cells. Taken together, the
effects of cell process formation and intercellular adhesion may partially account for the
effects of Myo10 knockdown on CNC cell migration.
Discussion
Our results show that Myo10 is selectively expressed in premigratory and migrating neural
crest cells in the early Xenopus embryo. We further show that it plays a critical role in their
migration, partly by influencing cell adhesive interactions. We hypothesize that these
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changes in adhesive behavior may underlie the role of Myo10 activity in influencing neural
crest migration.
Myo10 in neural crest specification
At early neurula stages, Myo10-MO reduces the expression level of neural crest genes.
Since the expression of these markers is recovered for the most part by tailbud stages, it
seems likely that this reflects a delay rather than an inhibition of induction or specification.
In contrast, loss-of-Myo10 function profoundly affects the subsequent migratory behavior of
cranial neural crest cells.
During neural crest specification, Myo10 may be linked to the activity of signals involved in
specifying the neural plate border and/or neural crest. For example, BMP6 has been shown
to activate Myo10 in endothelial cells, and Myo10, in turn, provides positive feedback to
BMP signals (Pi et al., 2007). Since BMP signaling is required for neural crest specification,
an intriguing possibility is that Myo10 modulates BMP activity, causing a partial inhibition
of specification. However, neither inhibition nor excess BMP appears to affect the
expression of Myo10 in the early Xenopus embryo (Supplementary Figure 1), suggesting
that these events may be uncoupled in early development. Alternatively, they may be
compensated by other signaling pathways, such as Wnts, thus accounting for a delay rather
than complete inhibition of the induction process upon knock-down of Myo10. Another
intriguing possibility is that Myo10 may affect the amplification of neural crest progenitor
pool. In Xenopus oocyte and epithelial cells, Myo10 has been shown to control the assembly
of meiotic and mitotic spindles (Weber et al., 2004; Woolner et al., 2008). However, we
failed to observed apparent effects of altering Myo10 activity on neural crest cell
proliferation.
Myo10 in neural crest migration
Our results both in vitro and in vivo suggest that Myo10 is required for normal migration of
neural crest cells and their cell-cell interactions. After Myo10 knock-down, CNC cells only
migrate half the distance towards the branchial arches and exhibit an impaired ability to
adhere to one another.
Several signaling pathways have been implicated in the control of neural crest migration.
Repulsive signals are important for confining neural crest cells to appropriate pathways. In
particular, receptor/ligand interactions of Eph/ephrin, Neuropilin/Semaphorin, and Slit/Robo
play roles in regulating the migration of different neural crest populations (Smith et al.,
1997; Helbling et al., 1998; Santiago and Erickson, 2002; Davy and Soriano, 2005; Jia et al.,
2005; Gammill et al., 2006, 2007; Mellott and Burke, 2008). Interestingly, these ligand/
receptor pairs are expressed in complementary patterns on neural crest cells and the
neighboring mesoderm, where they function to prevent cells from entering prescribed
regions adjacent to their migratory paths. Ephs have been shown to modify the activity of
phosphatidylinositol-3 kinase (PI3K) and Rho GTPase Cdc42 in various systems
(Fukushima et al., 2006; Bisson et al., 2007; Groeger and Nobes, 2007). Since Myo10 acts
downstream of Cdc42 in filopodial formation and may mediate PI3K signal by its PH
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domains, an intriguing possibility is that Myo10 may interact with Ephs to control neural
crest migration.
Attractive signals have also been suggested to positively regulate cell migration, though
little is known about chemoattractive signals for the neural crest. A netrin receptor deleted in
colorectal cancer (DCC) has been implicated in guiding neural crest cells as they migrate to
the developing bowel and pancreas. During neurite outgrowth, Myo10 can regulate the
cellular distribution of DCC (Jiang et al., 2003; Zhu et al., 2007). Non-canonical Wnt
signaling plays an important role in directional migration of Xenopus neural crest cells.
Inhibition of Wnt11 signaling dramatically blocks neural crest migration (Calisto et al.,
2005; Matthews et al., 2008a, 2008b). In addition, non-canonical Wnt has been shown to
underlie contact inhibition of locomotion in neural crest cells, thus regulating their migration
(Carmona-Fontaine et al., 2008). This may occur by modulating cytoskeleton and cell
protrusions mediated by Rho GTPases Rho and Rac. Whether or not there is cross-talk
between Myo10 and Wnt signals remains to be determined.
Myo10 regulates cell adhesion
Cells require adhesive interactions with either each other and/or an extracellular substrate in
order to actively migrate. During cell migration, cells first flatten and spread on the matrix to
maximize their adhesions. The points of contact are stabilized at the leading edge of the cell
while the adhesion between the trailing edge and the matrix is released so that the cell body
can be pulled forward.
Our in vitro culture data suggests that Myo10 is required for adhesion of neural crest cells
and to the extracellular matrix. After knockdown of Myo10, neural crest cells attached but
fail to spread on fibronectin substrates, instead remaining rounded. In mammalian cells,
Myo10 has been shown to translocate β1-integrin to the tips of filopodia (Zhang et al.,
2004). A similar mechanism may operate in neural crest cells to regulate cell-matrix
interaction.
Cell-cell adhesion is also important for cell movement. Groups of cells tend to move in a
directional fashion (Winklbauer et al., 1992). In neural crest cells, their movement along
prescribed pathways is mediated by contact inhibition of locomotion via non-canonical Wnt
signaling pathways (Carmona-Fontaine et al., 2008). Our in vitro results suggest that Myo10
is involved in maintaining contacts between neural crest cells. Furthermore, knockdown of
Myo10 in vivo results in intermingling of neural crest cells between different branchial arch
streams and abnormal migration patterns. Although the downstream regulators of these
adhesive events are not yet known, cadherins are likely candidates for players in cell-cell
adhesion since neural crest cells express specific members of cadherins during different
stages of development. In the chick, neural crest cells switch from cadherin 6B, which is
down-regulated during delamination, to cadherin 7 during migration (Nakagawa and
Takeichi, 1995). In Xenopus, cadherin 11 is turned on when the neural crest begins to
migrate (Hadeball et al., 1998). Our results suggest that Myo10 may be involved directly or
indirectly in controlling cell adhesive properties that sort cells into distinct migratory
pathways, perhaps by modulating cadherins.
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Myo10 and cell protrusions
The best-studied activity of Myo10 is in filopodial induction and extension. Filopodia are
important membrane protrusive structures important for cell adhesion, movement and
guidance. They sense the cell's surroundings and act as sites for signal transduction (Mattila
and Lappalainen, 2008). In migrating neural crest cells, both filopodia and lamellipodia are
actively extended and withdrawn. Studies in chick demonstrate that the front tier of cells in
the migrating neural crest population are typically comprised of cells with filopodia
distributed around their entire circumference, while the middle of the migratory streams
contains cells with bipolar filopodia (Teddy and Kulesa, 2004). In Xenopus, it has been
proposed that filopodia play important roles in short-range and long-range communication
for path finding. For example, inhibition of Wnt11 signaling by Dsh-DEP+ causes massive
formation of filopodia in neural crest cells, which consequently, fail to migrate (Calisto et
al., 2005). Our results are consistent with the intriguing possibility that Myo10 may function
as molecular motor in filopodial formation and extension during CNC cell migration, as
previously shown in other system (Bohil et al., 2006).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Myo10 is expressed in neural crest tissues during Xenopus development
Myo10 expression is first observed in Xenopus embryos at late gastrula stages, at the
borders of the forming neural plate, where the neural crest will arise. Expression
subsequently increases in the cranial neural crest and continues as they migrate towards the
branchial arches. By tailbud stages, the expression decreases, mainly remaining in the
cranial ganglia. All embryos are oriented with anterior to the left.
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Figure 2. Myo10-MO disrupted expression of neural crest genes
(A) Embryos were injected with control or Myo10-MO (10ng) in one cell at the two-cell
stage, thus labeling one side (labeled with red-gal staining, bottom half in dorsal view and
right panel in lateral view, marked by *). The subsequent expression of neural or neural crest
genes was examined at later stages. While the expression of neural marker Sox3 was
unaffected, the levels of neural crest genes Snail2, Sox10 and Twist were altered in the half
of the embryo that received Myo10-MO. Co-expression of a low dose (50–100pg) Myo10
mRNA efficiently rescued the defect. (B) Percentages of embryos with different levels of
neural crest gene expression (combining Snail2, Sox10 and Twist) at neurula stages. While
over 75% of control-MO injected embryos showed symmetric neural crest gene expression,
Myo10-MOs reduced the neural crest gene expression severely in over 25% of embryos and
altered the expression mildly in 45% of the embryos. Nearly 70% of the embryos were
rescued to normal levels by coexpressing Myo10 RNA. (C) Percentage of embryos with
defected neural crest migration indicated by the expression of Sox10 and Twist at tailbud
stages. Myo10-MOs lead to shorter and disorganized CNC migration in about 70% of the
embryos and co-injection of Myo10 reduced that to 18%.
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Figure 3. High-resolution images of Snail2 expression
Myo10-MO injected Embryos stained with Snail2 (as in Figure 2) were imaged either at
higher magnification or after transverse section. Upper panels were dorsal views of embryos
in whole mount, with anterior to the left; bottom panels were 10 m sections through the
embryos with dorsal to the top. * marks the injected side. np, neural plate. Although the
numbers of cells expressing transcript were approximately the same on left and right sides,
the level of expression was markedly lower on the Myo10-MOinjected side of the embryo.
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Figure 4. Cell proliferation and cell death is not affected by Myo10-MO
Embryos were stained with antibody to phospho-histone H3 to mark proliferating cells or
processed for TUNEL staining to detect cells undergo apoptosis. (A) Whole embryos were
cleared to visualize the internal staining. Embryos are shown in dorsal view, with anterior to
the left. Injections were done in the bottom half (marked by *). (B) Transverse sections were
oriented with dorsal side up, injected side to the right (marked by *). Closing neural plate
and closed neural tube were marked as np or nt. (C) Numbers of proliferating or dying cells
on the injected side versus uninjected side were compared. Sections of 10 embryos were
counted for each group and no significant changes were observed (p=0.50, 0.36 for cell
proliferation and cell death).
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Figure 5. Myo10 is not required for neural crest induction in AC assay
Animal caps were dissected from untreated embryos as well as those exposed to Wnt3a plus
noggin, with or without Myo10-MO. Caps were stained against neural crest markers Snail2
and Twist at st.13 and st.14. While control explants remain round and did not express any
neural crest genes, explants receiving Wnt3a and noggin started to express Snail2 and Twist
weakly at st.13 and strongly at st.14 and the shapes of the caps become irregular. Myo10-
MO did not inhibit either the expression of neural crest genes in the explants or the shape
changes of the explants.
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Figure 6. Myo10 is required for cranial neural crest (CNC) explants to spread and segregate on
FN matrix
(A) CNC explants were dissected from early neurula embryos receiving control or Myo10-
MO and plated on FN. By 7 hours, control-MO expressing explants spread extensively and
segregated into three cell streams. However, Myo10-MO expressing explants failed to
spread on FN, but dissociated into loose and rounded cells. The addition of low dose Myo10
rescued the effect partially. Distinct cell streams were marked by numbers. (B) The surface
areas of each explant at the beginning and the end of the experiment were compared and the
ratios of explant spreading summarized. Myo10-MOs reduced the ratio of spreading from
2.85 folds to 1.36 folds, while coexpressing Myo10 mRNA restored it to 2.77 folds. (C) The
number of segments formed for each explants was counted and compared. While control-
MO expressing explants were able to segregate into an average of 2.6 pieces, Myo10-MO
reduced this to 1.3. With the addition of low dose Myo10, explants made 2.2 segments on
average. For both the spreading and segregation, the disruption by Myo10-MOs and the
rescue by Myo10 were significant.
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Figure 7. Myo10 is required for CNC migration in vivo
(A) GFP labeled CNC explants were grafted into unlabeled host embryos and imaged at
tailbud stages. Fluorescent images and merge images are shown side by side. While control-
MO receiving grafts migrated laterally into mandibular arch, hyoid arch, and branchial
arches, Myo10-MOs expressing grafts failed to migrate efficiently and the migration paths
were often indistinguishable. Co-expression with Myo10 restored this to normal levels. (B)
Confocal images of the grafts show that control cells interacted with each other and
followed their routes of migration to segregate cleanly into three streams. In contrast,
Myo10-MO expressing cells did not appear to interact with neighboring cells. (C) Grafts
were placed into four categories based on their migration behavior. While over 80% of
control grafts migrate and segregate normally, over 24% of the Myo10-MO expressing
grafts failed to migrate at all. Another 60% migrated much shorter distances, half of which
did not segregate. Co-expressing Myo10 rescued the migration phenotype, with nearly 70%
of the grafts migrating normally. All embryos are shown in lateral view, with dorsal up,
anterior left.
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Figure 8. Myo10-MO inhibited the formation of cranial cartilage
Cartilages in late tadpoles were stained with alcian blue. Ventral view of the cranial cartilage
with anterior to the top, and injected side marked by *. Cartilage on the Myo10-MO injected
side was often malformed or even completely missing. Neural crest derived cartilages are
marked as: M, meckel's cartilage; CH, ceratohyal cartilage; CB, ceratobranchial cartilage.
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Figure 9. Myo10-MO disrupted cell adhesion and polarization of CNC cells
(A) CNC cells were dissociated and plated on FN-matrix. While control-MO expressing
cells spread on FN and extend membrane protrusions actively, most Myo10-MO expressing
cells remain round. A low dose of Myo10 mRNA together with Myo10-MO efficiently
rescued the phenotype, resulting in normal cell morphology. Bottom panels are higher
magnification views. Arrows point to the filopodial protrusions while arrowheads indicate
lamellipodia. For those few Myo10-MO expressing cells that appeared polarized, only very
short protrusions were observed. (B) Spreading cells were counted and their ratios among
the entire population were calculated. Myo10-MO dropped the percentage of spreading cells
from over 15% to around 6% while Myo10-MO plus Myo10 mRNA resulted in 13% cell
spreading, significantly different from Myo10-MO but not from controls. (C) Cell-cell
adhesion was examined by dissociation-reaggregation experiments. The same number of
explants were used for each experiment, and the number of cell clusters with diameters over
100μm were counted at the end of aggregation assay. While an average of 72 large cell
clusters were formed by control-MO cells, only ~20 large cell clusters were formed by
Myo10-MOs treated cells. Coexpression of Myo10 increased the number to 48 in average,
significantly different from that of MO alone. (D) Behaviors of labeled cells in CNC explant
were recorded by time-lapse movies. Frames with 6' intervals were shown. While control
cells migrated and extended membrane protrusions dynamically, Myo10-MO expressing
cells remained round and failed to form protrusions. The addition of Myo10 mRNA
efficiently rescued the ability to form protrusions and to migrate.
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